-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

653A.Oral3.6 653. Myeloma: Therapy, excluding Transplantation I Clinically Relevant Abstract

Myeloma: Therapy, excluding Transplantation Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
antibodies, Biological, Non-Biological, Therapies, CAR-Ts, chemotherapy, immunotherapy
Monday, December 11, 2017: 2:45 PM-4:15 PM
Bldg C, Lvl 1, Hall C1 (Georgia World Congress Center)
Moderators:
Vania T M Hungria, MD, PhD, Clinica São Germano and Jesus G. Berdeja, MD, Sarah Cannon Center For Blood Cancers
Disclosures:
Hungria: Celgene, Roche, Takeda, Janssen, Amgen: Honoraria.
2:45 PM

Meletios A. Dimopoulos1, Darrell J. White, MD2, Lofti Benboubker, MD3*, Gordon Cook, MD, PhD4*, Merav Leiba5*, James Morton6*, P. Joy Ho, MBBS, DPhil, FRACP, FRCPA, FFSc(RCPA)7*, Kihyun Kim8*, Naoki Takezako, MD, PhD9, Sonali Trivedi10*, Kaida Wu10, Tineke Casneuf11*, Christopher Chiu10, Jordan Schecter12* and Philippe Moreau13*

1National and Kapodistrian University of Athens, Athens, Greece
2Dalhousie University and QEII Health Sciences Centre, Halifax, NS, Canada
3Service d’Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France
4St James's Institute of Oncology, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, United Kingdom
5Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center,Tel Hashomer, Ramat Gan, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
6Icon Cancer Care, South Brisbane, QLD, Australia
7Institute of Haematology Royal Prince Alfred Hospital, Camperdown, NSW, Australia
8Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
9National Hospital Organization Disaster Medical Center, Tokyo, Japan
10Janssen Research & Development, Spring House, PA
11Janssen Research & Development, Beerse, Belgium
12Janssen Research & Development, LLC, Raritan, NJ
13Hematology, University Hospital Hôtel-Dieu, Nantes, France

3:00 PM

Jesus G. Berdeja, MD1, Yi Lin, MD, PhD2, Noopur Raje, MD3, Nikhil Munshi, MD4, David Siegel, MD, PhD5, Michaela Liedtke, MD6, Sundar Jagannath, MD7, Marcela V. Maus, MD, PhD3, Ashley Turka8*, Lyh Ping Lam, PharmD, RPh8*, Kristen Hege, MD9, Richard A. Morgan, PhD8, Michael Travis Quigley8* and James N. Kochenderfer, MD10

1Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Massachusetts General Hospital Cancer Center, Boston, MA
4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
5John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
6Department of Medicine, Stanford University School of Medicine, Stanford, CA
7Mount Sinai Hospital, New York, NY
8bluebird bio, Inc., Cambridge, MA
9Celgene Corporation, San Francisco, CA
10National Cancer Institute, National Institutes of Health Clinical Center, Bethesda, MD

3:15 PM

Suzanne Trudel, MD, FRCP(C)1, Nikoletta Lendvai, MD, PhD2, Rakesh Popat3*, Peter M. Voorhees, MD4, Brandi Reeves, MD5, Edward N. Libby III, MD6, Paul G Richardson, MD7, Larry Anderson, MD, PhD8, Heather Sutherland, MD9*, Kwee Yong, PhD10*, Axel Hoos, MD, PhD11*, Michele Gorczyca, MS11*, Soumi Lahiri, PhD11*, Zangdong He, PhD11*, Roxanne C Jewell, PhD12*, Joanna B. Opalinska, MD, PhD11 and Adam D. Cohen, MD13

1University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
2MSKCC, New York, NY
3University College London Hospitals NHS Foundation Trust, London, United Kingdom
4Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC
5Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
6Seattle Cancer Care Alliance, Seattle, WA
7Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
8UT Southwestern Medical Center, Dallas, TX
9Leukemia/Bone Marrow Transplant Program of British Columbia, BC Cancer Agency, Vancouver, BC, Canada
10UCL Cancer Institute, London, United Kingdom
11GlaxoSmithKline, Collegeville, PA
12GlaxoSmithKline, RTP, NC
13Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

3:30 PM

Eric L Smith, MD, PhD1, Sham Mailankody, MBBS2*, Arnab Ghosh, MBBS, PhD3*, Reed Masakayan, MS4*, Mette Staehr, PhD5*, Terence J Purdon, MS5*, Elizabeth Halton, NP5*, Claudia Diamonte, RN5*, Pavan Anant5*, Yvette Bernal, MS6*, Xiuyan Wang, PhD7*, Yongzeng Wang, PhD8*, Sarah Garrett9*, Steven Almo, PhD10*, Pei Wang, PhD11*, Hong Liu, MD, PhD12*, Yiyang Xu, PhD11*, Elena Mead, MD13*, Jae H. Park, MD14, Kevin J. Curran, MD3, Craig S. Sauter, MD15, Sergio A. Giralt, MD16, Ola Landgren, MD, PhD17, Ahmet Dogan, MD, PhD18, Mikhail Roshal, MD PhD18, Cheng Liu, PhD11*, Isabelle Riviere, PhD7* and Renier J. Brentjens, MD, PhD19

1Department of Medicine, Myeloma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY
2MSKCC, New York, NY
3Memorial Sloan-Kettering Cancer Center, New York, NY
4Agenus Inc, Lexington, MA
5Memorial Sloan Kettering Cancer Center, New York, NY
6Memorial Sloan Kettering Cncer Center, New York
7Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY
8Memorial Sloan kettering Cancer Center, New York, NY
9Albert Einstein College of Medicine, bronx, NY
10Albert Einstein College of Medicine, Bronx, NY
11Eureka Therapeutics, Inc., Emeryville, CA
12Eureka Therapeutics, Inc., Everyville, CA
13Anesthesiology-Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY
14Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
15Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
16Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
17Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
18Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
19Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

3:45 PM

A. Keith Stewart, MBChB, MBA1, David Siegel, MD, PhD2, Heinz Ludwig, MD3, Thierry Facon, MD4*, Hartmut Goldschmidt, MD 5, Andrzej J. Jakubowiak, MD6, Jesus F. San Miguel, MD7, Mihaela Obreja8*, Julie Blaedel8* and Meletios A. Dimopoulos9

1Center for Individualized Medicine, Mayo Clinic, Scottsdale, AZ
2John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
3Wilhelminen Cancer Research Institute, Vienna, Austria
4Centre Hospitalier Regional Universitaire (CHRU) Lille, Hopital Huriez, Lille, France
5University Hospital of Heidelberg, Heidelberg, Germany
6Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
7Centro de Investigación Médica Aplicada, University of Navarra, Clinica Universidad de Navarra, Pamplona, Spain
8Amgen, Inc., Thousand Oaks, CA
9National and Kapodistrian University of Athens, Athens, Greece

4:00 PM

Alessandra Larocca1*, Massimo Offidani, MD2, Pellegrino Musto, MD2, Francesca Patriarca, MD2*, Lorenzo De Paoli, MD2*, Paolo Corradini, MD2, Marco Salvini, MD1*, Clotilde Cangialosi, MD2*, Tommasina Guglielmelli, MD2*, Giovannino Ciccone3*, Fausto Dore, MD2*, Angelo Belotti, MD2*, Mattia D'Agostino, MD1*, Felicetto Ferrara, MD2*, Daniela Oddolo1*, Riccardo Centurioni, MD2*, Fabrizio Ciambelli, MD2*, Stefano Spada1*, Donatella Iolanda Vincelli, MD2*, Michele Cavo, MD2*, Nicola Giuliani, MD, PhD2, Alberto Bosi, MD2*, Concetta Conticello, MD2*, Roberto Ria, MD2*, Maria Teresa Petrucci, MD2* and Mario Boccadoro1

1Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
2Italian Multiple Myeloma Network, GIMEMA, Italy
3Unit of Cancer Epidemiology, University of Torino and CPO Piemonte, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy

*signifies non-member of ASH